Published by
@ShahidNShah
@ShahidNShah
Merck, GlaxoSmithKline, AbbVie, Sanofi & Bristol Myers Squibb: Big Pharma’s Extending Digital Health Reaches
A few weeks ago, we kickstarted a new series of articles contemplating the moves of pharmaceutical heavyweights in the digital health arena. The first batch of companies, Johnson & Johnson, Pfizer, Bayer and Novartis, seem to have some interest in remote healthcare solutions and DTx.
In this second article, we will explore which trends pharma giants Merck, GlaxoSmithKline, AbbVie, Sanofi and Bristol Myers Squibb are eyeing.
Continue reading at medicalfuturist.com
Make faster decisions with community advice
- 4 Best Practices to Foster Virtual Care Transformation for Providers
- EHR Systems Have 3 Major Hurdles To Overcome Before They Can Truly Improve Patient Care
- EHR Testing: Specifics And Best Practices
- Ethical Data Sharing: Securely Gleaning Insights From Clinical Data
- Mitigating Healthcare's Most Common Types Of Security Breaches
Next Article
-
Mitigating Healthcare's Most Common Types Of Security Breaches
In simple terms, a data breach is a security incident where a company's sensitive information is accessed without authorization. However, a data breach is more complex than just a leak or an exposure …
Posted Oct 26, 2021 Cybersecurity
